25.09.2020 • News

Polyplastics Plans German Polymers Plant

Japanese engineering plastics specialist Polyplastics has announced plans to build a cyclic olefin copolymer (COC) production plant in Leuna, Germany, to meet growing global demand for its Topas COC polymers.

To be operated by local Polyplastics subsidiary Topas Advanced Polymers, the new plant will have a capacity of 20,000 t/y, more than doubling the company’s current output. Startup is scheduled by mid-2023.

Polyplastics has been producing COCs in Oberhausen, Germany, since 2000. The company said it has developed a broad range of applications for, which is certified as recyclable and also is becoming a crucial component in medical devices.

In July, Celanese agreed to sell its 45% share in Polyplastics to partner Daicel for $1.575 billion. The deal, which will give Daicel full control of Polyplastics, is set to close later this year.

Daicel said making Polyplastics a wholly-owned subsidiary will allow it to accelerate the restructuring of its plastics segment, which accounts for 40% of its revenues.

Polyplastics will build a cyclic olefin copolymer (COC) production plant in...
Polyplastics will build a cyclic olefin copolymer (COC) production plant in Leuna, Germany, to meet growing global demand for its Topas polymers. The 20,000 t/y plant will more than double current output when it starts up by mid-2023. (c) Polyplastics

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read